Search research articles
Contact Us
Filters
Showing results (291-300 of 337) with videos related to
Page
of 34
Sort By:
Acta Neuropathologica
|
November 12, 2013
Histologically defined central nervous system primitive neuro-ectodermal tumours (CNS-PNETs) display heterogeneous DNA methylation profiles and show relationships to other paediatric brain tumour types
Ed C Schwalbe, James T Hayden, Hazel A Rogers, et al.
Acta Neuropathologica Communications
|
November 21, 2013
Identification of a neuronal transcription factor network involved in medulloblastoma development
Maria Lastowska, Hani Al-Afghani, Haya H Al-Balool, et al.
Genes & Development
|
November 2, 2005
The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation
Tamar Uziel, Frederique Zindy, Suqing Xie, et al.
Neuropathology and Applied Neurobiology
|
August 12, 2020
The molecular landscape and associated clinical experience in infant medulloblastoma: prognostic significance of second-generation subtypes
D Hicks, G Rafiee, E C Schwalbe, et al.
Nature Communications
|
August 30, 2020
Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity
Yura Grabovska, Alan Mackay, Patricia O'Hare, et al.
Scientific Reports
|
October 19, 2017
Minimal methylation classifier (MIMIC): A novel method for derivation and rapid diagnostic detection of disease-associated DNA methylation signatures
E C Schwalbe, D Hicks, G Rafiee, et al.
Acta Neuropathologica
|
May 12, 2019
Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes
Tanvi Sharma, Edward C Schwalbe, Daniel Williamson, et al.
Journal of Veterinary Internal Medicine
|
March 7, 2012
A randomized trial investigating the efficacy and safety of water soluble micellar paclitaxel (Paccal Vet) for treatment of nonresectable grade 2 or 3 mast cell tumors in dogs
D M Vail, H von Euler, A W Rusk, et al.
Acta Neuropathologica
|
April 4, 2023
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification
Jack Goddard, Jemma Castle, Emily Southworth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2012
Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial
Birgitta Lannering, Stefan Rutkowski, Francois Doz, et al.
Page
of 34
Search research articles
Search
Showing results (291-300 of 337) with videos related to
Sort By:
Page
of 34
Acta Neuropathologica
|
November 12, 2013
Histologically defined central nervous system primitive neuro-ectodermal tumours (CNS-PNETs) display heterogeneous DNA methylation profiles and show relationships to other paediatric brain tumour types
Ed C Schwalbe, James T Hayden, Hazel A Rogers, et al.
Acta Neuropathologica Communications
|
November 21, 2013
Identification of a neuronal transcription factor network involved in medulloblastoma development
Maria Lastowska, Hani Al-Afghani, Haya H Al-Balool, et al.
Genes & Development
|
November 2, 2005
The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation
Tamar Uziel, Frederique Zindy, Suqing Xie, et al.
Neuropathology and Applied Neurobiology
|
August 12, 2020
The molecular landscape and associated clinical experience in infant medulloblastoma: prognostic significance of second-generation subtypes
D Hicks, G Rafiee, E C Schwalbe, et al.
Nature Communications
|
August 30, 2020
Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity
Yura Grabovska, Alan Mackay, Patricia O'Hare, et al.
Scientific Reports
|
October 19, 2017
Minimal methylation classifier (MIMIC): A novel method for derivation and rapid diagnostic detection of disease-associated DNA methylation signatures
E C Schwalbe, D Hicks, G Rafiee, et al.
Acta Neuropathologica
|
May 12, 2019
Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes
Tanvi Sharma, Edward C Schwalbe, Daniel Williamson, et al.
Journal of Veterinary Internal Medicine
|
March 7, 2012
A randomized trial investigating the efficacy and safety of water soluble micellar paclitaxel (Paccal Vet) for treatment of nonresectable grade 2 or 3 mast cell tumors in dogs
D M Vail, H von Euler, A W Rusk, et al.
Acta Neuropathologica
|
April 4, 2023
Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification
Jack Goddard, Jemma Castle, Emily Southworth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 2, 2012
Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial
Birgitta Lannering, Stefan Rutkowski, Francois Doz, et al.
Page
of 34